CD80 and neoplasm: Previous studies reported that epigenetic agents can improve the immunogenicity and susceptibility of tumor cells to immune cells by up-regulating the expression of MHC class I molecules5, 40 and co-stimulatory molecules such as CD40, CD80, and CD8630, 32, 33.